What are the limitations of the bariatric surgery eligibility ifso asmbs?

While the bariatric surgery eligibility ifso asmbs is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the bariatric surgery eligibility ifso asmbs to ensure safe bedside use and optimal diagnostic accuracy.

How does the bariatric surgery eligibility ifso asmbs compare to other Endocrinology scores?

The bariatric surgery eligibility ifso asmbs is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the bariatric surgery eligibility ifso asmbs free to use?

Yes. OpiCalc provides the bariatric surgery eligibility ifso asmbs completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Assess

Patients with obesity failing conservative weight loss efforts.
Patients with difficult-to-control obesity-associated conditions (Type 2 Diabetes, Severe OSA, NAFLD).

CLINICAL INSIGHT

How it Works

2022 ASMBS/IFSO Indication Criteria Update

Condition	Prior Criteria (1991)	New 2022 Criteria
BMI threshold alone	≥ 40 kg/m²	≥ 35 kg/m²
BMI + Comorbidity	≥ 35 kg/m²	≥ 30 kg/m²
Asian Population Thresholds	N/A	BMI ≥ 27.5 kg/m²
Adolescents	Restrictive	Considered generally eligible for selected youth

CLINICAL INSIGHT

Practical Pearls

Paradigm Shift

Preoperative Clearance

CLINICAL INSIGHT

Next Steps

Procedure Selection (Brief guide)

Sleeve Gastrectomy: Preferred for general severe obesity, least technical complications, but worse severe reflux (GERD) outcomes.
Roux-en-Y Gastric Bypass (RYGB): Gold standard for uncontrolled Type 2 Diabetes and severe GERD. Higher risk of malabsorption.
Biliopancreatic Diversion (BPD/DS): Greatest weight loss, reserved for extreme obesity (BMI >50), highest risk of profound malnutrition.

CLINICAL INSIGHT

Evidence Base

Guidelines

2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery

Eisenberg D, et al.Surg Obes Relat Dis2022

Clinical Reference Hub

When to Use

When to Assess

How it Works

2022 ASMBS/IFSO Indication Criteria Update

Practical Pearls

Paradigm Shift

Preoperative Clearance

Next Steps

Procedure Selection (Brief guide)

Evidence Base

Guidelines

Bariatric Surgery Eligibility (IFSO/ASMBS)

Clinical Reference Hub

When to Use

When to Assess

How it Works

2022 ASMBS/IFSO Indication Criteria Update

Practical Pearls

Paradigm Shift

Preoperative Clearance

Next Steps

Procedure Selection (Brief guide)

Evidence Base

Guidelines

Bariatric Surgery Eligibility (IFSO/ASMBS)

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Assess

How it Works

2022 ASMBS/IFSO Indication Criteria Update

Practical Pearls

Paradigm Shift

Preoperative Clearance

Next Steps

Procedure Selection (Brief guide)

Evidence Base

Guidelines

Bariatric Surgery Eligibility (IFSO/ASMBS)

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Assess

How it Works

2022 ASMBS/IFSO Indication Criteria Update

Practical Pearls

Paradigm Shift

Preoperative Clearance

Next Steps

Procedure Selection (Brief guide)

Evidence Base

Guidelines

Bariatric Surgery Eligibility (IFSO/ASMBS)